KARACHI, Pakistan – Pakistan is taking steps to produce coronary stents domestically as a way to improve the delivery of health care at home and, perhaps, tap into a growing global market.
N-ovative Health Technologies Pvt. Ltd., spun out of the National University of Science and Technology (NUST), started mass production of cardiac stents and angioplasty balloon catheters in October. It is the first such manufacturing facility in the country.
Adagio Medical Inc., a company focused on the treatment of atrial fibrillation (AF) and ventricular tachycardia (VT), has scooped up $42.5 million in a series E equity financing. The funds are earmarked for the ongoing IDE trial of its intelligent Continuous Lesion Ablation System (iCLAS). They will also be used to accelerate the European VT CE mark study, advance the commercialization of iCLAS in CE-mark countries and further development and clinical validation of its pulsed field cryoablation technology.
Keeping you up to date on recent developments in cardiology, including: New cardiac arrest resuscitation treatment demonstrated 100% success rate in cannulation; How additional heart imaging can help certain women; Heart development protein has role in adult immunity.
The FDA has issued Sanofi SA a complete response letter (CRL) regarding its complement pathway inhibitor sutimlimab, citing deficiencies found during a pre-license inspection of a third-party manufacturing facility.
New and updated preclinical and clinical data presented by biopharma firms at the 2020 American Heart Association Scientific Sessions Nov. 13-17, including: Acceleron, Astrazeneca, Cytokinetics, Daiichi, Myokardia, Silence.
Acutus Medical Inc. posted strong results for the third quarter of 2020, despite the ongoing uncertainties of the COVID-19 pandemic. Sales for the quarter totaled $3.2 million, up 180% sequentially and 391% when compared with the same period in 2019.
RSS
